P

Inventor

MAZE MERVYN

GB15 patents
⚠️ This page may combine multiple inventors who share the name “MAZE MERVYN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PROTEXEON LTD

4 patents
US6653354B2Nov 25, 2003

NMDA antagonist comprising xenon

PROTEXEON LTD27 citations90
US7390508B2Jun 24, 2008

Use of xenon with hypothermia for treating neonatal asphyxia

PROTEXEON LTD7 citations71
US7632872B2Dec 15, 2009

Analgesic agent for newborn or fetal subjects

PROTEXEON LTD5 citations60
US7442383B2Oct 28, 2008

Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass

PROTEXEON LTD5 citations60

UNIV CALIFORNIA

3 patents
US9708247B2Jul 18, 2017

Modulators of the eIF2alpha pathway

UNIV CALIFORNIA14 citations88
US10343981B2Jul 9, 2019

Modulators of the eIF2alpha pathway

UNIV CALIFORNIA6 citations79
US11220477B2Jan 11, 2022

Modulators of the eIF2alpha pathway

UNIV CALIFORNIA0 citations58

THE KENNEDY TRUST FOR RHEUMATOLOGY RES

2 patents
US11220540B2Jan 11, 2022

Methods for reducing post-operative cognitive dysfunction (POCD)

THE KENNEDY TRUST FOR RHEUMATOLOGY RES2 citations63
US12325744B2Jun 10, 2025

Methods for reducing post-operative cognitive dysfunction (POCD)

THE KENNEDY TRUST FOR RHEUMATOLOGY RES0 citations54

UNIV LELAND STANFORD JUNIOR

1 patent
US6567702B1May 20, 2003

Eliciting analgesia by transcranial electrical stimulation

UNIV LELAND STANFORD JUNIOR184 citations97

IMPERIAL COLLEGE

1 patent
US6274633B1Aug 14, 2001

NMDA antagonist

IMPERIAL COLLEGE36 citations91

(unassigned)

1 patent
US6562855B1May 13, 2003

Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist

24 citations90

ORION YHTYMAE OY

1 patent
US5344840ASep 6, 1994

4-substituted imidazole derivatives useful in perioperative care

ORION YHTYMAE OY23 citations89

MAZE MERVYN

1 patent
US9308254B2Apr 12, 2016

Method for treatment of post operative cognitive dysfunction

MAZE MERVYN6 citations73

IMP INNOVATIONS LTD

1 patent
US9326996B2May 3, 2016

Use of xenon as neuroprotectant in a neonatal subject

IMP INNOVATIONS LTD0 citations51